Edition:
United Kingdom

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

5.41USD
22 Mar 2019
Change (% chg)

-- (--)
Prev Close
$5.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
22,165
52-wk High
$6.77
52-wk Low
$2.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -0.380
Sep '18 0.00 -0.252
Jun '18 0.00 -0.454
Mar '18 0.00 -1.027
FY 2017 Dec '17 0.00 -0.625
Sep '17 0.00 -0.296
Jun '17 0.00 -0.288
Mar '17 0.00 -0.079
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 3 0.00 0.00 0.00 --
Quarter Ending Jun-19 3 0.00 0.00 0.00 --
Year Ending Dec-19 4 0.00 0.00 0.00 --
Year Ending Dec-20 3 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Mar-19 3 -0.43 -0.41 -0.46 --
Quarter Ending Jun-19 3 -0.52 -0.40 -0.65 --
Year Ending Dec-19 3 -1.62 -1.54 -1.72 --
Year Ending Dec-20 3 -1.19 -0.97 -1.59 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.30 32.54
P/E High - Last 5 Yrs. -- 43.23 48.15
P/E Low - Last 5 Yrs. -- 22.71 23.42
Beta -- 0.86 0.87
Price to Sales (TTM) -- 6.59 8.39
Price to Book (MRQ) 2.07 5.12 5.27
Price to Tangible Book (MRQ) 2.07 5.84 6.74
Price to Cash Flow (TTM) -- 23.07 24.12
% Owned Institutions 0.28 0.87 1.65

Dividends

  Company industry sector
Dividend Yield -- 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 3.99 4.70
Payout Ratio(TTM) -- 42.18 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 6.61 8.02
Sales - 5 Yr. Growth Rate -- 10.48 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -212.06 45.67 47.68
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.47
Capital Spending - 5 Yr. Growth Rate -- 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) 4.85 2.87 2.98
LT Debt to Equity (MRQ) 1.45 8.87 11.35
Total Debt to Equity (MRQ) 23.49 12.87 16.02
Interest Coverage (TTM) -- 32.47 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 52.10 52.41
Gross Margin - 5 Yr. Avg. -- 49.66 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.26 12.43
Operating Margin (TTM) -- 13.53 5.77
Operating Margin - 5 Yr. Avg. -- 13.69 8.02
Pre-Tax Margin (TTM) -- 11.90 4.80
Pre-Tax Margin - 5 Yr. Avg. -- 14.11 8.31
Net Profit Margin (TTM) -- 8.81 1.53
Net Profit Margin - 5 Yr. Avg. -- 10.60 4.72
Effective Tax Rate (TTM) -- 22.12 22.13
Effective Tax Rate - 5 Yr. Avg. -- 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 928,329,132 820,308,580
Net Income/Employee (TTM) -- 105,132,015 92,854,694
Receivable Turnover (TTM) -- 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.41
Asset Turnover (TTM) -- 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.98 10.60
Return on Assets - 5 Yr. Avg. -- 12.41 11.78
Return on Investment (TTM) -- 14.23 13.82
Return on Investment - 5 Yr. Avg. -- 16.18 15.32
Return on Equity (TTM) -- 15.46 15.24
Return on Equity - 5 Yr. Avg. -- 17.07 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 39.21 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Avenue Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.54%
# of Holders: 11
Total Shares Held: 749,547
3 Mo. Net Change: 25,732
# New Positions: 1
# Closed Positions: 3
# Increased Positions: 4
# Reduced Positions: 6
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.